VOR

Vor Biopharma (VOR)

About Vor Biopharma (VOR)

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Boston, MA.

Details

Daily high

$15.86

Daily low

$13.01

Price at open

52 Week High

$65.80

52 Week Low

$2.62

Market cap

296.0M

Dividend yield

0.00%

Volume

3,903

Avg. volume

3.3M

P/E ratio

-.03

Vor Biopharma News